Detalles de la búsqueda
1.
Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patients.
BMC Cancer
; 15: 73, 2015 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-25879885
2.
Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: role of heat shock proteins and dissecting effects of hyperthermia.
Ann Surg Oncol
; 20(4): 1105-13, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23456378
3.
Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: a multicenter study.
Ann Surg Oncol
; 18(6): 1560-7, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21203904
4.
Optimizing of preoperative computed tomography for diagnosis in patients with peritoneal carcinomatosis.
World J Surg Oncol
; 9: 171, 2011 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-22188796
5.
Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin.
BMC Cancer
; 10: 689, 2010 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-21176206
6.
Morbidity and mortality of 109 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC) performed at a community hospital.
World J Surg
; 34(1): 62-9, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20020294
7.
The importance of radiological controls of anastomoses after upper gastrointestinal tract surgery - a retrospective cohort study.
Patient Saf Surg
; 4(1): 17, 2010 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-21070633
Resultados
1 -
7
de 7
1
Próxima >
>>